<DOC>
	<DOCNO>NCT01005251</DOCNO>
	<brief_summary>This study carry see whether AZD3355 effective treatment add-on PPI therapy patient Gastroesophageal Reflux Disease ( GERD ) partial response PPI compare Proton Pump Inhibitor ( PPI ) treatment alone . Another goal study examine investigate dos AZD3355 optimal treatment patient . This study also measure level drug blood see well tolerate .</brief_summary>
	<brief_title>Investigate Effect Different Doses Lesogaberan ( AZD3355 ) add-on PPI GERD Patients With Partial Response PPI</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Lesogaberan</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Have least 6 month history GERD Continuously treat last 4 week enrolment daily optimize unchanged PPI therapy GERD indication Patients experience GERD symptom improvement PPI treatment Prior surgery upper gastrointestinal tract . Subject follow condition disease : Heart disease , Angina , Seizure disorder epilepsy , Congestive Heart Failure ( CHF ) , Liver disease Cirrhosis Hepatitis , Kidney disease , Lung disease lung cancer , Cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>GERD treatment</keyword>
	<keyword>Acid non-acid Reflux</keyword>
	<keyword>Heartburn</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>Add-on treatment PPI</keyword>
</DOC>